1 of 1
Story summary
- CVS Pharmacy Inc. agreed to pay $315 million to settle DOJ lawsuit over opioid prescriptions.
- The DOJ alleged CVS violated the Controlled Substances Act and False Claims Act from Oct 17 2013 to Dec 2 2025.
- CVS filled excessive early-refill and “trinity” prescriptions from providers operating as “pill mills.”
- Those prescriptions were billed to Medicaid, Medicare and other federal health-care programs.
- CVS must add safeguards, create a DEA hotline, and monitor suspicious prescribing.